Biofrontera AG BFRA

Biofrontera AG DSO 2011-2026 | BFRA

DSO Jährlich Biofrontera AG

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
42.2	58.8	59.7	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
59.7	42.2	53.5

DSO anderer Aktien in der Pharmaeinzelhändler

Name	DSO	Preis	% 24h	Marktkapitalisierung	Land
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Amgen AMGN	81.2	$ 345.02	1.52 %	$ 186 B	USA
Amneal Pharmaceuticals AMRX	55.7	$ 12.59	2.19 %	$ 3.95 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	106	$ 23.65	1.63 %	$ 3.01 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.43	4.78 %	$ 381 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.86	2.74 %	$ 9.29 B	Australia
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	150	$ 2.66	3.5 %	$ 16.7 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.03	-	$ 6.59 B	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Cerus Corporation CERS	47	$ 1.95	5.99 %	$ 372 M	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 9.61	-1.06 %	$ 128 M	USA